Search results
Dow Jones Futures: Apple AI Push, Fed Rate Outlook Lead 8 Big Market Events
Investor's Business Daily· 2 hours agoFDA Panel Reviews Eli Lilly's Alzheimer's Drug An FDA advisory panel on Monday will review Eli...
The Potential Benefits and Dangers of Rewiring the Brain
Mercola· 2 days agoThe panel includes neuroscientists Takao Hensch and John Krakauer, as well as entrepreneur Brett Wingeier, co-founder and CEO of Magnus Medical. This capacity could potentially ...
US FDA staff raise no major concerns about Eli Lilly Alzheimer's drug
Colorado Springs Gazette· 4 days agoThe drug is a potential rival to Eisai and Biogen's Leqembi, which won approval last July. Both treatments are antibodies designed to remove toxic beta amyloid plaques from the brains of people with early Alzheimer's disease.
Selma Blair Hits The Red Carpet With Guide Dog, Scout
Women's Health via AOL· 4 days agoSelma Blair has been open about her multiple sclerosis health journey since she was diagnosed in...
New York Fed Is Losing Talent and ‘Street Cred’ Under John Williams
Bloomberg via Yahoo Finance· 6 hours agoToday he oversees an institution that many veteran market participants worry has suffered a brain...
This injectable gel can help to diagnose brain injury — then it disappears
Nature· 5 days agoThe squishy sensors could be used to monitor the brain for tumours or injury, before eventually...
BA family says son was able to beat brain cancer right here in Tulsa thanks to St. Jude
FOX23 News· 2 days agoA Broken Arrow family said their son was able to beat brain cancer right here in Tulsa thanks to St....
Digital games may be an overlooked ally in mental health
Medical Xpress· 4 days agobrain-training games, collections of puzzles and quizzes that are marketed to help sharpen the mind...
Eli Lilly’s Alzheimer’s drug to face safety, dosing scrutiny from FDA advisers
Market Watch· 3 days agoThere was no comparison group to show outcomes in similar patients if they had continued treatment,...
FDA Panel Rejects MDMA Drug for PTSD
Medscape· 5 days agoA US Food and Drug Administration (FDA) expert panel has found that the benefits of the psychedelic midomafetamine (MDMA) in combination with psychological intervention for ...